Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr-cas9
2
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
a2 biotherapeutics
aduro biotech
agency
agios therapeutics
akili interactive labs
alicia hager
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
arca biopharma
arch venture partners
arrowhead pharmaceuticals
axovant gene therapies
bacteriophage
base editing
biogen
biontech
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
branden moriarty
bridgebio
bristol-myers squibb
broad institute
cancer
cancer immunotherapy
cas13
charles rice
chinook therapeutics
What
crispr
2
×
scientists
2
×
alliance
beam
bio
bristol
buy
calls
cas
changing
color
days
editas
editing
editor
founders
gene
gotten
growing
harvard
hours
jump
kudos
leaves
mass
medicine
myers’s
notifying
october
phone
precise
rnai
roundup
rouse
shorter
slumber
spotlights
startup
therapeutics
time
Language
unset
Current search:
crispr
×
crispr-cas9
×
scientists
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
